Clinical Niche FDA approved non-drug pressure stimulation device for preventing nausea and vomiting in perioperative and cancer care settings, presenting a specialized cross-selling opportunity to hospitals, surgical centers, and oncology departments seeking non-pharmacologic antiemetic options.

Surgical & Oncology Systems Target procurement and contract opportunities within hospitals and clinics that manage post-operative nausea and chemotherapy-induced nausea, aligning with existing care pathways and formulary considerations to drive adoption.

Patient Outcomes Emphasize safety and patient satisfaction improvements to support value-based care narratives, offering a non-drug alternative that may reduce antiemetic drug exposure, potential opioid sparing effects, and shorter post-op stays.

Digital & Brand Growth Leverage the current web and CMS stack (Squarespace, WordPress) to pilot clinician-facing landing pages and traffic sources, enabling faster digital marketing experiments and physician outreach via targeted content.

Growth Potential With modest revenue and a small team, pursue partnerships or distributors in healthcare markets to scale adoption, while highlighting scalability through a simple, non-drug medical device that fits into existing hospital purchasing processes.